Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 307

    1.

    Extranodal marginal zone lymphoma of the uterine corpus.

    Wright TM, Rule S, Liu H, Du MQ, Smith ME.

    Leuk Lymphoma. 2012 Mar 13. [Epub ahead of print] No abstract available.

    PMID:
    22288559
    [PubMed - as supplied by publisher]
    2.

    Employment and insurance in survivors of Hodgkin lymphoma and their siblings: a questionnaire study.

    Chen AB, Feng Y, Neuberg D, Recklitis C, Diller LR, Mauch PN, Ng AK.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print]

    PMID:
    22280535
    [PubMed - as supplied by publisher]
    3.

    Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone.

    Goto N, Tsurumi H, Takemura M, Kanemura N, Kasahara S, Hara T, Yasuda I, Shimizu M, Yamada T, Sawada M, Takahashi T, Yamada T, Seishima M, Moriwaki H, Takami T.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print]

    PMID:
    22280534
    [PubMed - as supplied by publisher]
    4.

    Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma.

    Dimou M, Angelopoulou MK, Pangalis GA, Georgiou G, Kalpadakis C, Pappi V, Tsopra O, Koutsoukos K, Zografos E, Boutsikas G, Moschogianni M, Vardounioti I, Petevi K, Karali V, Kanellopoulos A, Ntalageorgos T, Yiakoumis X, Bartzis V, Bitsani A, Pessach E, Efthimiou A, Korkolopoulou P, Rassidakis G, Kyrtsonis MC, Patsouris E, Meletis J, Panayiotidis P, Vassilakopoulos TP.

    Leuk Lymphoma. 2012 Apr 2. [Epub ahead of print]

    PMID:
    22280533
    [PubMed - as supplied by publisher]
    5.

    Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group.

    Kim SJ, Moon JH, Kim H, Kim JS, Hwang YY, Intragumtornchai T, Issaragrisil S, Kwak JY, Lee JJ, Won JH, Reksodiputro AH, Lim ST, Cheng AL, Kim WS, Kwong YL.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print]

    PMID:
    22273250
    [PubMed - as supplied by publisher]
    6.
    7.

    Bortezomib in combination with R-DICE chemoimmunotherapy (VIPER) in patients with relapsed and primary refractory diffuse large B cell lymphoma.

    Elstrom RL, Andemariam B, Martin P, Ruan J, Shore TB, Coleman M, Leonard JP, Furman RR.

    Leuk Lymphoma. 2012 Jan 20. [Epub ahead of print]

    PMID:
    22263572
    [PubMed - as supplied by publisher]
    8.

    Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists.

    Cabrera ME, Martinez V, Nathwani BN, Muller-Hermelink HK, Diebold J, Maclennan KA, Armitage J, Weisenburger DD.

    Leuk Lymphoma. 2012 Mar 13. [Epub ahead of print]

    PMID:
    22263570
    [PubMed - as supplied by publisher]
    9.

    High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma.

    Procházka V, Faber E, Raida L, Langová K, Indrák K, Papajík T.

    Leuk Lymphoma. 2012 Feb 21. [Epub ahead of print]

    PMID:
    22263569
    [PubMed - as supplied by publisher]
    10.

    Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma.

    Thoennissen NH, Thoennissen GB, Abbassi S, Nabavi-Nouis S, Sauer T, Doan NB, Gery S, Müller-Tidow C, Said JW, Koeffler HP.

    Leuk Lymphoma. 2012 Feb 21. [Epub ahead of print]

    PMID:
    22260161
    [PubMed - as supplied by publisher]
    11.

    Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy.

    Huntington SF, Talbott MS, Greer JP, Morgan DS, Reddy N.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print]

    PMID:
    22260160
    [PubMed - as supplied by publisher]
    12.

    Interfollicular Hodgkin lymphoma in children: an uncommon mimicker of reactive lymphadenopathy.

    Cajaiba MM, Kahwash SB.

    Leuk Lymphoma. 2012 Feb 21. [Epub ahead of print] No abstract available.

    PMID:
    22260158
    [PubMed - as supplied by publisher]
    13.

    Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007.

    Chandran R, Gardiner SK, Simon M, Spurgeon SE.

    Leuk Lymphoma. 2012 Feb 13. [Epub ahead of print]

    PMID:
    22242824
    [PubMed - as supplied by publisher]
    14.

    Enteropathy-associated T-cell lymphoma in small intestine detected by capsule endoscopy.

    Kakugawa Y, Terasaka S, Watanabe T, Tanaka S, Taniguchi H, Saito Y.

    Leuk Lymphoma. 2012 Feb 3. [Epub ahead of print] No abstract available.

    PMID:
    22242819
    [PubMed - as supplied by publisher]
    15.

    Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.

    Dummer R, Beyer M, Hymes K, Epping MT, Bernards R, Steinhoff M, Sterry W, Kerl H, Heath K, Ahern JD, Hardwick JS, Garcia-Vargas J, Baumann K, Rizvi S, Frankel SR, Whittaker SJ, Assaf C.

    Leuk Lymphoma. 2012 Feb 13. [Epub ahead of print]

    PMID:
    22239668
    [PubMed - as supplied by publisher]
    16.

    Is autologous stem cell transplantation for transformed follicular lymphoma still justifiable?

    Dickinson M.

    Leuk Lymphoma. 2012 May;53(5):754-5. Epub 2012 Feb 13. No abstract available.

    PMID:
    22239667
    [PubMed - in process]
    17.

    CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies.

    Ito D, Frantz AM, Williams C, Thomas R, Burnett RC, Avery AC, Breen M, Mason NJ, O'Brien TD, Modiano JF.

    Leuk Lymphoma. 2012 Feb 3. [Epub ahead of print]

    PMID:
    22229753
    [PubMed - as supplied by publisher]
    18.

    Bendamustine: more ammunition in the battle against mantle cell lymphoma.

    Chang JE, Kahl BS.

    Leuk Lymphoma. 2012 Jan 31. [Epub ahead of print] No abstract available.

    PMID:
    22220986
    [PubMed - as supplied by publisher]
    19.

    Impact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan-melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma.

    Campbell P, Friebe A, Foulstone P, Grigg A, Hempton J, Bajel A.

    Leuk Lymphoma. 2012 Jan 31. [Epub ahead of print] No abstract available.

    PMID:
    22204452
    [PubMed - as supplied by publisher]
    20.

    A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma.

    Warsch S, Hosein PJ, Maeda LS, Alizadeh AA, Lossos IS.

    Leuk Lymphoma. 2012 Jan 31. [Epub ahead of print]

    PMID:
    22185662
    [PubMed - as supplied by publisher]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk